Siddiqui says the study showed that the rapid antigen test was high in sensitivity (ability to identify people for whom the PCR test would detect a SARS-CoV-2 infection) at 92.7% for all ...

Scientists from Hokkaido University have shown that an antigen-based test for quantifying SARS-CoV-2 in saliva samples is simple, rapid, and more conducive for mass-screening.

As the need for rapid diagnosis of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) increases, due to the relentless surge in coronavirus disease 2019 (COVID-19) cases ...

Deep mutational scanning identifies SARS-CoV-2 Nucleocapsid escape mutations of currently available rapid antigen tests. Cell , 2022; 185 (19): 3603 DOI: 10.1016/j.cell.2022.08.010 Cite This Page : ...

Basel, 01 February 2021- Roche today announced it has obtained the CE mark for its new SARS-CoV-2 Rapid Antigen Test Nasal. Whether the test could also be used without supervision of a healthcare ...

The combination rapid antigen test quickly differentiates between SARS-CoV-2 and influenza viruses A and B infections, with results ready in less than 30 minutes, allowing informed decisions on ...

Basel, 1 September 2020- Roche announced today that it will launch a SARS-CoV-2 Rapid Antigen Test, in late September, for markets accepting the CE Mark. Roche also intends to file for Emergency ...

The rapid COVID-19 antigen tests are a lateral flow test – the same format as a home pregnancy test – that includes a test strip containing SARS-CoV-2 antibodies. First, the sample is collected from ...

LONDON, Oct. 15, 2021 /PRNewswire/ -- LumiraDx (Nasdaq: LMDX), a next-generation point of care diagnostic company, today announced it has submitted the LumiraDx SARS-CoV-2 & Flu A/B Test to the ...

TIANJIN, China, Nov. 30, 2021 /PRNewswire/ -- JOYSBIO, one of the world's leading manufacturers of lateral flow rapid tests, is proud to announce that their tests are available around the world ...

Scientists from Hokkaido University have shown that an antigen-based test for quantifying SARS-CoV-2 in saliva samples is simple, rapid, and more conducive for mass-screening.